Evaluating Treatment Response of Chronic Myeloid Leukemia: Emerging Science and Technology

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|7|779-790

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.7, 2013-09, pp. : 779-790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging drugs for chronic myeloid leukemia

By Cilloni Daniela   Messa Emanuela   Rotolo Antonia   Saglio Giuseppe  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 175-184

Informa Healthcare

Access to resources Recommend Favorite

Emerging Therapies in Chronic Myeloid Leukemia

By  

Current Cancer Drug Targets, Vol. 12, Iss. 5, 2012-05 ,pp. : 458-470

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment options for chronic myeloid leukemia

By Tanaka Maria Florencia   Kantarjian Hagop   Cortes Jorge   Ohanian Maro   Jabbour Elias  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 815-828

Informa Healthcare

Access to resources Recommend Favorite

Treatment of chronic myeloid leukemia when imatinib fails

By Hehlmann Rüdiger   Jung-Munkwitz Susanne   Saußele Susanne  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 269-283

Informa Healthcare

Access to resources Recommend Favorite

Mathematical Modeling of Genesis and Treatment of Chronic Myeloid Leukemia

By  

Cells Tissues Organs, Vol. 188, Iss. 1-2, 2008-02 ,pp. : 236-247

Karger

Access to resources Recommend Favorite